drugset / Trial / NCT00651742
Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic Cancer
Phase 2
Completed
28 enrolled
Taiho Oncology, Inc.
Quintiles, Inc. · collabUnited BioSource, LLC · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether S-1 is effective in slowing tumor activity in participants with locally advanced or metastatic pancreatic cancer who have not had chemotherapy. The study is also looking at the safety of S-1.
Timeline
- Start
- 2006-01-09
- Primary completion
- 2008-07-08
- Completion
- 2008-07-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | S-1 | Small molecule | 30 mg/m2 | Oral |
Indications
No indication recorded.